Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cardiovascular Comorbidities in a United States Patient Population with Hemophilia a: A Comprehensive Chart Review

Jennifer Pocoski, Brittny Rule, Augustina Ogbonnaya, MPH, Lois Lamerato, PhD, Michael Eaddy, PharmD, PhD, Orsolya Lunacsek, Thomas J. Humphries

Blood (2016) 128 (22): 4966.

https://doi.org/10.1182/blood.V128.22.4966.4966

Published: 2016

Journal Articles

Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

Thomas J. Humphries, Nikki Church, Shadan Lalezari, Lone H. Poulsen, Mia Yoon, Monika Maas Enriquez

Blood (2016) 128 (22): 4984.

https://doi.org/10.1182/blood.V128.22.4984.4984

Published: 2016

Journal Articles

Associations Between Joint Damage and Quality of Life Among Patients with Severe Hemophilia a in the 3-Year Spinart Trial

Jennifer Pocoski, PharmD, Peggy L Lin, PhD, Walter Hong, MD, Sneha S Kelkar, MS, MPH, Tianze Jiao, PhD, Ella X Du, MS, Thomas J. Humphries, MD, Jipan Xie, MD PhD

Blood (2014) 124 (21): 200.

https://doi.org/10.1182/blood.V124.21.200.200

Published: 2014

Journal Articles

Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart

Jennifer Pocoski, PharmD, Benjamin Kim, MD MPhil, Thomas J. Humphries, MD, Walter Hong

Blood (2014) 124 (21): 1518.

https://doi.org/10.1182/blood.V124.21.1518.1518

Published: 2014

Journal Articles

Consequences of Switching From Prophylactic Treatment to On-Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A. the TEEN/TWEN Study

Marilyn J. Manco-Johnson, MD, Joann Sanders, MD, Nadia Ewing, MD, Thomas J. Humphries, MD

Blood (2011) 118 (21): 2288.

https://doi.org/10.1182/blood.V118.21.2288.2288

Published: 2011

NARROW

Cardiovascular Comorbidities in a United States Patient Population with Hemophilia a: A Comprehensive Chart Review

Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

Associations Between Joint Damage and Quality of Life Among Patients with Severe Hemophilia a in the 3-Year Spinart Trial

Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart

Consequences of Switching From Prophylactic Treatment to On-Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A. the TEEN/TWEN Study

Email alerts

ASH Publications

American Society of Hematology

Cardiovascular Comorbidities in a United States Patient Population with Hemophilia a: A Comprehensive Chart Review

Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

Associations Between Joint Damage and Quality of Life Among Patients with Severe Hemophilia a in the 3-Year Spinart Trial

Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart

Consequences of Switching From Prophylactic Treatment to On-Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A. the TEEN/TWEN Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only